Tomoko Yamazaki Selected Research

Tomoko Yamazaki Research Topics

Disease

16	Neoplasms (Cancer) 05/2024 - 11/2013
13	Head and Neck Neoplasms (Head and Neck Cancer) 12/2022 - 01/2016
8	Squamous Cell Carcinoma of Head and Neck 05/2024 - 09/2016
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2022 - 01/2019
4	Infections 09/2022 - 04/2012
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 05/2016
3	Adenocarcinoma 01/2022 - 01/2019
3	Disease Progression 01/2019 - 01/2003
3	Acute Kidney Injury (Acute Renal Failure) 06/2018 - 02/2016
2	Carcinogenesis 01/2023 - 11/2013
2	Hypopharyngeal Neoplasms 10/2022 - 10/2019
2	Anaplastic Thyroid Carcinoma 03/2019 - 01/2017
2	Thyroid Neoplasms (Thyroid Cancer) 03/2019 - 01/2017
2	Renal Insufficiency (Renal Failure) 06/2018 - 05/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2014 - 06/2013
1	Lung Neoplasms (Lung Cancer) 06/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Pneumonia (Pneumonitis) 12/2022
1	Neuroblastoma 10/2022
1	Nasopharyngeal Carcinoma 09/2022
1	Spondylitis 09/2022
1	Sepsis (Septicemia) 09/2022
1	Esophageal Neoplasms (Esophageal Cancer) 08/2022
1	Dehydration (Water Stress) 01/2022
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Dermatitis 11/2021
1	Febrile Neutropenia 09/2021
1	Cholangiocarcinoma 01/2021
1	Pain (Aches) 09/2020
1	Body Weight (Weight, Body) 09/2020
1	Oropharyngeal Neoplasms 06/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2020
1	Melanoma (Melanoma, Malignant) 10/2019
1	medullary Thyroid cancer 03/2019
1	Atherosclerosis 01/2019
1	Alcoholic Fatty Liver 06/2018
1	Fibrosis (Cirrhosis) 06/2018
1	Fatty Liver 06/2018

Drug/Important Bio-Agent (IBA)

7	NivolumabIBA 05/2023 - 03/2021
6	Proteins (Proteins, Gene)FDA Link 05/2024 - 02/2016
6	Adapalene (Differin)FDA LinkGeneric 05/2024 - 01/2019
5	Cetuximab (Erbitux)FDA Link 12/2022 - 01/2016
4	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 05/2024 - 01/2019
4	PlatinumIBA 12/2022 - 01/2016
3	Fluorouracil (Carac)FDA LinkGeneric 12/2022 - 07/2016
3	CytokinesIBA 01/2022 - 10/2008
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 07/2016
3	Immunoglobulin M (IgM)IBA 06/2018 - 10/2016
2	Monoclonal AntibodiesIBA 08/2022 - 10/2019
2	Capecitabine (Xeloda)FDA Link 01/2022 - 01/2022
2	Docetaxel (Taxotere)FDA Link 09/2021 - 07/2016
2	Biomarkers (Surrogate Marker)IBA 10/2019 - 01/2014
2	lenvatinibIBA 03/2019 - 01/2017
2	LipidsIBA 01/2019 - 01/2014
2	AntigensIBA 01/2019 - 06/2018
1	Messenger RNA (mRNA)IBA 05/2024
1	Untranslated RNA (Noncoding RNA)IBA 05/2024
1	Environmental CarcinogensIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 12/2022
1	pembrolizumabIBA 12/2022
1	Transcription Factors (Transcription Factor)IBA 10/2022
1	NF-kappa B (NF-kB)IBA 10/2022
1	ErbB Receptors (EGF Receptor)IBA 08/2022
1	Glycoproteins (Glycoprotein)IBA 08/2022
1	LY-2157299IBA 01/2022
1	Proton Pump InhibitorsIBA 01/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	Histamine H2 AntagonistsIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	SteroidsIBA 11/2021
1	nanolucIBA 01/2021
1	bis(4-methylumbelliferyl)pyrophosphateIBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	AlbuminsIBA 09/2020
1	C-Reactive ProteinIBA 09/2020
1	AntibodiesIBA 02/2020
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 10/2019
1	Formaldehyde (Formol)FDA Link 06/2019
1	ParaffinIBA 06/2019
1	Apolipoproteins E (ApoE)IBA 01/2019
1	CollagenIBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	LigandsIBA 01/2019
1	ApolipoproteinsIBA 01/2019
1	EnzymesIBA 06/2018
1	AutoantigensIBA 06/2018
1	ImmunosorbentsIBA 06/2018

Therapy/Procedure

10	Therapeutics 12/2022 - 01/2003
5	Chemoradiotherapy 09/2022 - 07/2016
4	Drug Therapy (Chemotherapy) 06/2023 - 01/2021
2	Radiotherapy 09/2022 - 01/2019
2	Neck Dissection (Radical Neck Dissection) 06/2021 - 01/2017
2	Enteral Nutrition (Feeding, Tube) 09/2020 - 09/2016
2	Cochlear Implantation 09/2014 - 04/2012
1	Catheters 09/2022
1	Neoadjuvant Therapy 01/2022
1	Skin Care 11/2021
1	Early Ambulation 09/2020
1	Length of Stay 01/2020
1	Premedication 08/2017